Vanda Pharmaceuticals Reports First Quarter 2026 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St slips as climbing oil, yields amplify inflation fears
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
| Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) | Delayed: 4.35 -0.21 (4.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.56 | 52 Week High | $18.00 | |||
| Open | $4.52 | 52 Week Low | $6.91 | |||
| Day High | $4.52 | P/E | N/A | |||
| Day Low | $4.35 | EPS | $-0.67 | |||
| Volume | 185,090 | |||||
